Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -34,308 | -23,431 | N/A | N/A |
| Depreciation Amortization | 900 | 751 | N/A | N/A |
| Accounts receivable | -146 | 617 | N/A | N/A |
| Accounts payable and accrued liabilities | 43 | 1,176 | N/A | N/A |
| Other Working Capital | 177 | -8,267 | N/A | N/A |
| Other Operating Activity | 119 | -2,852 | 0 | 0 |
| Operating Cash Flow | $-33,215 | $-32,006 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 7,668 | 28,117 | N/A | N/A |
| PPE Investments | -307 | -884 | N/A | N/A |
| Other Investing Activity | -998 | 0 | 0 | 0 |
| Investing Cash Flow | $6,363 | $27,233 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 1,578 | 0 | N/A | N/A |
| Debt Repayment | -113 | -45 | N/A | N/A |
| Common Stock Issued | 270 | 217 | N/A | N/A |
| Financing Cash Flow | $1,735 | $172 | $N/A | $N/A |
| Beginning Cash Position | 41,070 | 45,671 | N/A | N/A |
| End Cash Position | 15,953 | 41,070 | N/A | N/A |
| Net Cash Flow | $-25,117 | $-4,601 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -33,215 | -32,006 | N/A | N/A |
| Capital Expenditure | -317 | -884 | N/A | N/A |
| Free Cash Flow | -33,532 | -32,890 | 0 | 0 |